about
Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and PodocytesRole of Neuropilin-1 in Diabetic NephropathyPericytes, an overlooked player in vascular pathobiologyNFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db miceGlypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney.Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy.Analysis of the glomerular basement membrane in images of renal biopsies using the split-and-merge method: a pilot studyCannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.Defining the molecular character of the developing and adult kidney podocyte.Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy.ANG II promotes autophagy in podocytesSegmentation and analysis of the glomerular basement membrane in renal biopsy samples using active contours: a pilot study.Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney diseaseCharacterization and culture of fetal rhesus monkey renal cortical cells.Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.Preventive effects of green tea (Camellia sinensis var. assamica) on diabetic nephropathy.CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro.High glucose induces autophagy in podocytes.The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney DiseaseNotch signaling in diabetic nephropathyGlomerular cell death and inflammation with high-protein diet and diabetesPodocytopathy in diabetes: a metabolic and endocrine disorderThe antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosisEffect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy.Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal InjuryErk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes.The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.Pathophysiology of the diabetic kidney.Investigation of phosphoproteome in RAGE signaling.Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.New insights: A role for O-GlcNAcylation in diabetic complications.CTGF mediates high-glucose induced epithelial-mesenchymal transition through activation of β-catenin in podocytes.The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes.
P2860
Q26778527-01D3BD4D-48FC-4443-8058-D984D952254CQ26799448-3306A542-9DF6-4C1B-A462-05F1E4E16E8BQ28070053-516B487E-773C-4470-866B-9F7F69185321Q28661524-29150985-6521-49F9-B1D4-4CB87F11AE39Q30383052-A66A3571-B91A-4EDD-A15D-301DFFAEFDEEQ30501075-408567D6-111C-4F81-96A2-5F7A0F4816A2Q33504243-EACD246F-D3D3-4E67-81F7-7AB7E968E61DQ33750632-3679550C-522D-4C75-A382-5A225493BA92Q34023821-048360D6-178B-4101-921A-4D2C4B4F913BQ34024258-31B9FC3C-278A-4ED2-B9C0-585B7AFA5B84Q34085732-992FD9CC-A704-4C23-81D0-A4D1E391D9EAQ34614604-6F756928-0F77-46A3-8702-8F8D63A46E38Q34773888-0E1F19BE-E91F-4200-88E7-D75649CBD782Q35217148-47A0EAC0-EE20-495D-884F-2D303073A7F0Q35219396-5641171B-0FF2-4184-9C20-99465E7551EDQ35303442-DE7E9D10-328D-4BB1-A1DA-53A14EA65058Q35648209-24585B1A-ADB2-4654-90B8-F24FBD496C56Q35893390-741110A8-C411-4211-850B-373209E41705Q36531604-B67A9866-571A-4BBF-82EA-BA94C69EB4E7Q36773098-C9397155-BC03-41F7-BE0C-E7A64D260155Q36822302-22E9CD42-42DF-4E19-AD4A-2B5E813537A3Q36916676-994A5489-B192-4DF1-B35C-83096F418711Q37000229-415BD44E-C0F4-44A3-B636-18104F347F1EQ37036858-9B5A132B-DD83-4D98-A8A4-998F8BEB83ACQ37142515-F7086184-54CF-40B8-B2E2-F2F5A2D6AA4CQ37260645-325C4DA5-99E9-4D19-B82C-AA9C0D4CCEADQ37269247-57167272-061A-4DAC-ABB0-C15089C42EF6Q37317440-DA71AD17-96B5-4857-AD5A-E4EA5610399DQ37392107-A080211E-3B2B-4EA2-895F-B90128C9D742Q37482925-AA51EA6E-A249-4AA4-A985-94A4E677D41EQ37510406-E5F12D5D-5C70-4E76-8C4D-B34FB8E2E9C7Q37597721-2450EF3E-FEE4-437B-B93C-7E3B5C7876E7Q37725607-55305D1A-2530-43B3-80FE-C81776D77EF7Q37997004-19B65F6D-FC56-41E7-80E1-04C4DF6D5D85Q38111707-BD904ADC-9F22-436B-949D-E54E8ED49C23Q38260264-CDD26444-FE53-43F4-85D7-5015ECEA5A6AQ38700920-0AEB6734-117F-450D-BC5A-7F127E05ABD1Q38710250-E1A681C2-6754-4192-A3FC-0F5EC8C40041Q38785733-95C5EA38-62EB-440C-B412-B6725D53DF4AQ39474702-23D6E240-6AB4-4B11-AE37-080534292809
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Podocyte biology in diabetic nephropathy.
@en
type
label
Podocyte biology in diabetic nephropathy.
@en
prefLabel
Podocyte biology in diabetic nephropathy.
@en
P2093
P356
P1476
Podocyte biology in diabetic nephropathy.
@en
P2093
P2888
P304
P356
10.1038/SJ.KI.5002384
P577
2007-08-01T00:00:00Z
P5875
P6179
1000912506